BioOutsource Opens New Facility in Glasgow

BioOutsource Ltd., part of Sartorius Stedim Biotech Group and a provider of biologics contract testing and biosimilar characterization for the biopharmaceutical industry, has opened a new facility that doubles its capacity for future growth.

“Our opening of this new, state-of-the-art facility demonstrates our commitment to our growing list of global customers,” said Gerry MacKay, chief executive officer, BioOutsource. “Demand for our services remains high and we are doubling our capacity to make sure we are ready to support the robust pipeline of biotech and biosimilar products currently in development. It is estimated that in opening and running the new facility, BioOutsource will create approximately 50 new jobs for scientific and technical professionals in the next six months.”